🇺🇸 FDA
Patent

US 8461192

Method of selectively inhibiting PKCiota

granted A61KA61K31/00A61K31/4164

Quick answer

US patent 8461192 (Method of selectively inhibiting PKCiota) held by The United States of America—Department of Veterans Affairs expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America—Department of Veterans Affairs
Grant date
Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/00, A61K31/4164, A61P, A61P35/00